Pediatric Rheumatology

Article	Citations
The successes and challenges of harmonising juvenile idiopathic arthritis (JIA) datasets to create a large-scale JIA data resource	48
Predictors of fibrogenesis in children with JIA: a single-center pilot study	43
Increasing the etanercept dose in a treat-to-target approach in juvenile idiopathic arthritis: does it help to reach the target? A post-hoc analysis of the BeSt for Kids randomised clinical trial	38
Algorithmic approach in the diagnosis of pediatric uveitis	37
Clinical features, treatment, and outcomes of celiac-associated arthritis: a retrospective cohort study	30
Peripheral blood regulatory T cells and disease activity, quality of life, and outcomes in children with juvenile idiopathic arthritis	27
Juvenile dermatomyositis: association between nail fold capillary end row loop– area under the curve– and disease damage indicators	24
Experiences of sexual and reproductive health screening and counseling in the clinical setting among adolescents and young adults with rheumatic disease	24
Musculoskeletal symptoms and their impact on health-related quality of life in chronic nonbacterial osteomyelitis patients	23
Serositis as an indicator of poor prognosis in pediatric systemic lupus erythematosus	22
Three cases of autoinflammatory disease with novel NLRC4 mutations, and the first mutation reported in the CARD domain of NLRC4 associated with autoinflammatory infantile enterocolitis (AIFEC)	20
Efficacy and safety of canakinumab in systemic juvenile idiopathic arthritis, the first Chinese experience	20
Efficacy and safety of telitacicept in children with IgA vasculitis and IgA vasculitis nephritis: a single-center retrospective study	20
Barriers to care in juvenile localized and systemic scleroderma: an exploratory survey study of caregivers’ perspectives	19
The protective effect of COVID-19 vaccines on developing multisystem inflammatory syndrome in children (MIS-C): a systematic literature review and meta-analysis	19
Consensus on transition care for juvenile idiopathic arthritis: a Delphi study with youth, caregivers, and health professionals	18
The clinical relevance of different antiphospholipid antibody profiles in pediatric rheumatology patients	18
A randomized controlled educational study to evaluate an e-learning module to teach the physical examination of the temporomandibular joint in juvenile idiopathic arthritis	18
Neurological involvement in children with familial Mediterranean fever: a systematic review	17
Natural autoimmunity in oligoarticular juvenile idiopathic arthritis	17
A roadmap for navigating child health research data sharing across Canada and beyond – building on UCAN CAN-DU	17
Proceedings of the 29th European Paediatric Rheumatology Congress	17
Investigating the association between SARS-CoV-2 infection, COVID-19 vaccination, and autoimmune diseases in a pediatric population: a comprehensive analysis	17
Pediatric immune-mediated necrotizing myopathy with anti-SRP antibodies targeting 19, 68, and 72 kda subunits	17
Therapeutic recreation camps for youth with childhood-onset systemic lupus erythematosus: perceived psychosocial benefits	16

Translating research into practice—implementation recommendations for pediatric rheumatology; Proceedings of the childhood arthritis and rheumatology research alliance 2020 implementation science retr	16
Relationship of regional ultraviolet index data with rash and systemic disease activity in youth with childhood-onset systemic lupus: results from the Childhood Arthritis and Rheumatology Research All	15
Infection with SARS-CoV-2 causes flares in patients with juvenile idiopathic arthritis in remission or inactive disease on medication	15
Adherence, helpfulness and barriers to treatment in juvenile idiopathic arthritis – data from a German Inception cohort	15
Immunoprofiling of active and inactive systemic juvenile idiopathic arthritis reveals distinct biomarkers: a single-center study	15
Meningococcal ACWY conjugate vaccine immunogenicity in adolescents with primary or secondary immune deficiencies, a prospective observational cohort study	15
Looking for the best strategy to treat children with new onset juvenile idiopathic arthritis: presentation of the “comparison of STep-up and step-down therapeutic strategies in childhood ARthritiS” (S	15
Myeloid-related protein 8/14 in plasma and serum in patients with new-onset juvenile idiopathic arthritis in real-world setting in a single center	15
Frequency of remission achievement in the pre-treat-to-target decade in juvenile idiopathic arthritis	15
Cytokines in saliva, serum, and temporomandibular joint synovial fluid in children with juvenile idiopathic arthritis: An explorative cross-sectional study	14
Correction: PSTPIP1-associated myeloid-related proteinaemia inflammatory (PAMI) syndrome; a case presenting as a perinatal event with early central nervous system involvement?	14
14-month-old female with anti-MDA5 juvenile dermatomyositis complicated by liver disease: a case report	14
Body mass index is associated with health-related quality of life and disease characteristics in young adults with juvenile idiopathic arthritis	14
Development of the paediatric society of the African league against rheumatism (PAFLAR) JIA registry and clinical profile of JIA in Africa from the PAFLAR JIA registry	14
Real-world comparison of the effects of etanercept and adalimumab on well-being in non-systemic juvenile idiopathic arthritis: a propensity score matched cohort study	14
Exploring paediatric rheumatology care: a ten-year retrospective analysis of the patient population in Ghana	14
Biologic switching patterns among children with non-systemic juvenile idiopathic arthritis	13
Identification of a variant in NLRP3 gene in a patient with Muckle-Wells syndrome: a case report and review of literature	13
Incidence and reasons for biologic and targeted synthetic DMARD switching in juvenile idiopathic arthritis: a real- life stratified analysis	13
How common is remission in rheumatoid factor-positive juvenile idiopathic arthritis patients? The multicenter Pediatric Rheumatology Academy (PeRA) research group experience	13
Developing consensus outcome measures in juvenile systemic sclerosis: a global survey of pediatric rheumatologists and literature review	12
Exploring the clinical profiles and management of juvenile dermatomyositis in Africa: a survey of African rheumatology care providers	12
Feasibility of quantitative sensory testing in juvenile idiopathic arthritis	12
Circulating prolactin level in Juvenile Systemic Lupus Erythematosus and its correlation with disease activity: a case control study	12
Juvenile dermatomyositis with Anti-SAE antibodies in a Moroccan child associated with pseudo-angioedema: a case report	12
Tapering of biological treatment in autoinflammatory diseases: a scoping review	12
Long noncoding RNAs (CTC-471J1.2, NeST) as epigenetic risk factors of active juvenile lupus nephritis: a case-control study	12
Screening for celiac disease in juvenile idiopathic arthritis	11
An iceberg I can’t handle: a qualitative inquiry on perceptions towards paediatric rheumatology among healthcare workers in Kenya	11
Maternal and infant outcomes of pregnancy associated with anti-SSA/RO antibodies: a systematic review and meta-analysis	11
Subcutaneous tocilizumab in the management of non-infectious uveitis in children: a brief report	11
Predictors of persisting pain in children with Juvenile Idiopathic Arthritis: a case control study nested in the ReACCh-Out cohort	11
Economic evaluation of infliximab, synthetic triple therapy and methotrexate in the treatment of newly diagnosed juvenile idiopathic arthritis	11
Differences between leukemic arthritis and juvenile idiopathic arthritis	11
Longitudinal assessment of preparation for care transition among adolescents and young adults with rheumatologic disease: a single-center pilot study	11
Humoral and cellular immune response to mRNA SARS-CoV-2 BNT162b2 vaccine in adolescents with rheumatic diseases	11
Restricted upper airway dimensions in patients with dentofacial deformity from juvenile idiopathic arthritis	10
A virtual pediatric rheumatology teaching initiative for physicians in Somaliland	10
Management of childhood-onset systemic lupus erythematosus (cSLE) over the last two decades in Spain	10
Epstein–Barr Virus encephalitis associated hemophagocytic lymphohistiocytosis in childhood-onset systemic lupus erythematosus: a case-based review	10
A novel PRKDC mutation caused B lymphocytes V(D)J rearrangement disorder in the SLE-DAH like symptoms patient	10
NLRP12-associated systemic autoinflammatory diseases in children	10
Mitigated suppressive function of regulatory T cells (Treg) upon Th17-inducing cytokines in oligo- and polyarticular Juvenile Idiopathic Arthritis (JIA) patients	9
Dengue infection triggered immune mediated necrotizing myopathy in children: a case report and literature review	9
Factors associated with care- and health-related quality of life of caregivers of children with juvenile idiopathic arthritis	9
Structural ultrasound of joints and tendons in healthy children: development of normative data	9
A qualitative evaluation of the specific carbohydrate diet for juvenile idiopathic arthritis based on children’s and parents’ experiences	9
Bone mineral density in egyptian children with juvenile idiopathic arthritis: possible correlation to serum RANKL / osteoprotegerin (OPG) ratio and OPG gene polymorphisms	9
Treatment escalation patterns to start biologics in refractory moderate juvenile dermatomyositis among members of the Childhood Arthritis and Rheumatology Research Alliance	9
Prospective study to characterize adalimumab exposure in pediatric patients with rheumatic diseases	9

Kawasaki disease in Kenya and review of the African literature	9
Chronic non-bacterial osteomyelitis in children- five-year standardized follow-up of a prospective observational cohort in the pre-biological era	9
Hypertension as a prominent manifestation secondary to renal artery lesions in pediatric Behcet’s disease	9
Assay for interferon gamma release as a novel marker in pediatric patients with systemic lupus erythematosus	8
Correction: Transition readiness among finnish adolescents with juvenile idiopathic arthritis	8
Whole-exome sequencing analysis identifies novel variants associated with Kawasaki disease susceptibility	8
Utility of patient-reported outcomes for pulmonary symptoms and sleep disturbance and impairment in children with systemic juvenile idiopathic arthritis	8
High prevalence of sacroiliitis and early structural changes in the sacroiliac joint in children with enthesitis-related arthritis: findings from a tertiary centre in Hong Kong	8
Capillary microscopy is a potential screening method for connective tissue disease in children with Raynaud’s phenomenon	8
Modified Delphi study to identify priority clinical questions for the Australian living guidelines for the management of Juvenile Idiopathic Arthritis	8
Axial involvement in enthesitis-related arthritis: results from a single-center cohort	8
Characterizing lupus in African American children in Southern United States	8
Clinical outcomes and safety of anakinra in the treatment of multisystem inflammatory syndrome in children: a single center observational study	8
MicroRNA-27a-3p enhances the inflammatory phenotype of Juvenile Idiopathic Arthritis fibroblast-like synoviocytes	8
Monogenic disorders as mimics of juvenile idiopathic arthritis	8
Depression and anxiety in childhood-onset systemic lupus erythematosus: prevalence, associated factors, and impact on quality of life and family	8
Scurvy masquerading as IgA vasculitis	8
Feasibility of applying infrared thermal imaging for home monitoring of arthritis in children	8
Changes over time in inflammatory and structural lesions at the sacroiliac joint in children with spondyloarthritis exposed and unexposed to tumor necrosis factor inhibitor	8
Bone health and physical activity in adolescents with juvenile idiopathic arthritis: a cross-sectional case-control study	8
Implementation study of the CARRA Uveitis Consensus Treatment Plans: feasibility for clinical practice and applicability for research	7
Towards a histological diagnosis of childhood small vessel CNS vasculitis	7
ANCA-negative eosinophilic granulomatosis with polyangiitis in a girl misdiagnosed as asthma and pulmonary tuberculosis	7
Transition readiness in adolescents and young adults with chronic rheumatic disease in Oman: today’s needs and future challenges	7
Paediatric autoimmune diseases with ELANE mutations associated with neutropenia	7
Panniculitis with late onset enthesitis-related arthritis: a case report	7
Overlap syndrome in a 12-year-old girl with systemic lupus erythematosus and anti-oj antibody-positive polymyositis: a case report	7
Discontinuation of biologic DMARDs in non-systemic JIA patients: a scoping review of relapse rates and associated factors	7
High rheumatoid factor does not diminish efficacy of TNF inhibitors in seropositive JIA	7
Correction: Importance of pediatric rheumatologists and transitional care for juvenile idiopathic arthritis-associated uveitis: a retrospective series of 9 cases	7
Mental comorbidities in adolescents and young adults with juvenile idiopathic arthritis: an analysis of German nationwide health insurance data	7
Disease relapse rate in children with autoimmune rheumatic diseases after COVID-19 infection and vaccination	7
Musculoskeletal involvement in childhood leukemia: Characteristics and survival outcomes	7
Part 5: Allogeneic HSCT in refractory SJIA with lung disease; recent cases from centers in North America & Europe	7
Pain-coping scale for children and their parents: a cross-sectional study in children with musculoskeletal pain	7
Towards a standardized program of transitional care for adolescents with juvenile idiopathic arthritis for Turkey: a national survey study	6
Bacterial infection in patients with juvenile systemic lupus erythematosus and fever	6
Clinical characteristics and prognostic factor in juvenile dermatomyositis: data of the Spanish registry	6
Effect of exercise training on heath, quality of life, exercise capacity in juvenile idiopathic arthritis: a meta-analysis of randomized controlled trials	6
An updated overview of Juvenile systemic sclerosis in a French cohort	6
Beneficial effects of anti-apolipoprotein A-2 on an animal model for coronary arteritis in Kawasaki disease	6
A case of ANCA-associated vasculitis in a 16-year-old female following SARS-COV-2 infection and a systematic review of the literature	6
Systemic juvenile idiopathic arthritis in French Afro-Caribbean children, a retrospective cohort study	6
PSTPIP1-associated myeloid-related proteinaemia inflammatory (PAMI) syndrome; a case presenting as a perinatal event with early central nervous system involvement?	6
Incidence, prevalence, and comorbidities of juvenile idiopathic arthritis in Germany: a retrospective observational cohort health claims database study	6
What have we learned from long-term studies in juvenile idiopathic arthritis? – Prediction, classification, transition.	6
Prevalence of spine pain among Tunisian children and adolescents and related factors	6
Is an association of acro-osteolysis, bone fragility, and enchondromatosis a newfound disease caused by an amplification of PTHLH? A case report	6
Nodular Regenerative Hyperplasia of the liver in Juvenile Dermatomyositis	6
Correction: Engaging patients and parents to improve mental health intervention for youth with rheumatological disease	6
Nailfold videocapillaroscopy in patients with deficiency of adenosine deaminase 2 (DADA2): a case-control study	6
“I’d like more options!”: Interviews to explore young people and family decision-making needs for pain management in juvenile idiopathic arthritis	6
Unveiling the uncommon: diagnostic journey of camurati-engelmann disease in a pediatric patient	6
Physical (in)activity and screen-based media use of adolescents with juvenile idiopathic arthritis over time - data from a German inception cohort	6
Kawasaki disease with an asymptomatic reversible splenial lesion	6
Non-criteria antiphospholipid antibodies and pediatric rheumatic disease: a case series	6
Accuracy and adequacy of photoprotection in pediatric systemic lupus erythematosus patients, and the effect of education on photoprotection: a prospective study	6
Musculoskeletal pain and its effect on daily activity and behaviour in Icelandic children and youths with juvenile idiopathic arthritis: a cross-sectional case-control study	6
Th17/1 and ex-Th17 cells are detected in patients with polyarticular juvenile arthritis and increase following treatment	5
International multidisciplinary consensus on the definition and clinical approach for monogenic inflammatory immune dysregulation disorders	5
The effect of TNF treatment uptake on incident hospital admission in Western Australia	5
Aquaporin-4 IgG antibodies: predictors of positivity and their relationship with neuropsychiatric disorders and white matter lesions in Juvenile systemic lupus erythematosus	5
The use of ECMO in pediatric granulomatosis with polyangiitis	5
Serine, N-acetylaspartate differentiate adolescents with juvenile idiopathic arthritis compared with healthy controls: a metabolomics cross-sectional study	5
Activated phosphoinositide 3-kinase δ syndrome caused by PIK3CD mutations: expanding the phenotype	5
Synchronous disease onset and flares in siblings with PFAPA	5
A novel frameshift variant in the ADA2 gene of a patient with a neurological phenotype: a case report	5
Dry synovitis, a rare entity distinct from juvenile idiopathic arthritis	5
Still’s disease: bridging the gap between guidelines and clinical practice	5
The relationships of kinesiophobia and physical function and physical activity level in juvenile idiopathic arthritis	5
The 4th NextGen therapies of SJIA and MAS, part 4: it is time for IL-18 based trials in systemic juvenile idiopathic arthritis?	5
Children’s experiences of a support program during their first year with juvenile idiopathic arthritis	5
Clinical characteristics and prognosis of interstitial lung disease in systemic juvenile idiopathic arthritis: a two-center retrospective observational cohort study	5
A retrospective comparative analysis of factors affecting the decision and outcome of initial intravenous immunoglobulin alone or intravenous immunoglobulin plus methylprednisolone use in children wit	5
Proceedings of the 2024 Childhood Arthritis and Rheumatology Research Alliance (CARRA) Annual Scientific Meeting	5
Novel multiple Z-score models for detection of coronary artery dilation: application in Kawasaki disease	5
Exploring pediatric onset Still’s disease patient journey and parental perceptions in Türkiye through a survey	5
Currently recommended skin scores correlate highly in the assessment of patients with Juvenile Dermatomyositis (JDM)	5
A mixed-method systematic review evaluating interventions in paediatric rheumatology to address caregiver support and well-being	5
Increased vascular deposition of oxidized LDL in untreated juvenile dermatomyositis	5

Quality improvement in juvenile idiopathic arthritis: a mixed-methods implementation pilot of the CAPTURE-JIA dataset	5
Nailfold capillary density in 140 untreated children with juvenile dermatomyositis: an indicator of disease activity	5
Bayesian trial of adalimumab versus secukinumab for children with juvenile idiopathic arthritis associated uveitis or chronic anterior uveitis	5
Juvenile diabetes and systemic sclerosis: just a coincidence?	5
Publisher Correction: Musculoskeletal involvement in childhood leukemia: Characteristics and survival outcomes	5
Aicardi-Goutières syndrome type 6: report of ADAR variant and clinical outcome after ruxolitinib treatment in the neonatal period	4
The 4th NextGen therapies for SJIA and MAS: part 3 clinical trials in refractory SJIA: historic controls as an alternative to a withdrawal design study	4
Safety and effectiveness of intravenous abatacept for polyarticular-course juvenile idiopathic arthritis: An all-case postmarketing surveillance study	4
α2-fraction and haptoglobin as biomarkers for disease activity in oligo- and polyarticular juvenile idiopathic arthritis	4
Uveitis associated with juvenile arthritis: a continued cohort study 40 years after uveitis onset	4
Baseline characteristics of children with juvenile dermatomyositis enrolled in the first year of the new Childhood Arthritis and Rheumatology Research Alliance registry	4
Childhood-onset Takayasu arteritis: clinical presentation, challenges and disease course	4
Subtype frequency, demographic features, treatment and outcome of Juvenile Arthritis in one Centre in Abu Dhabi in the United Arab Emirates	4
C-reactive protein to high density lipoprotein cholesterol ratio for predicting coronary artery lesions, and intravenous immunoglobulin resistance in Kawasaki disease	4
Reverse complete heart block using transcutaneous pacing and repeated plasmapheresis in a neonate with lupus: a case report	4
The 4th NextGen therapies for SJIA and MAS: part 2 phenotypes of refractory SJIA and the landscape for clinical trials in refractory SJIA	4
Clinical observations on infliximab treatment of infantile onset Takayasu arteritis	4
“Online survey of COVID-19 immunization and infection in patients with systemic juvenile idiopathic arthritis and adult-onset still’s disease.”	4
Juvenile eosinophilic fasciitis: a single center case series	4
Pediatric antiphospholipid syndrome: clinical features and therapeutic interventions in a single center retrospective case series	4
Epidemiology and demographics of juvenile idiopathic arthritis in Africa and Middle East	4
Lymphocyte apoptosis and its association with the inflammatory markers and disease severity in juvenile-onset systemic lupus erythematosus patients	4
Tofacitinib effectiveness in Blau syndrome: a case series of Chinese paediatric patients	4
Impact of anakinra use on clinical outcomes in children with moderate or severe multisystem inflammatory syndrome in children: a propensity score matched retrospective cohort study	4
Clinical features of Kawasaki disease initially mimicking retropharyngeal abscess: a retrospective analysis	4
Revising the WHO Essential Medicines List for paediatric rheumatology update	4
Correction: Safety and effectiveness of intravenous abatacept for polyarticular-course juvenile idiopathic arthritis: An all-case postmarketing surveillance study	4
Colchicine treatment can be discontinued in a selected group of pediatric FMF patients	4
Touraine-Solente-Gole syndrome: pathogenic variant in SLCO2A1 presented with polyarthralgia and digital clubbing	4
Rheumatic fever in a developed country – is it still relevant? A retrospective, 25 years follow-up	4
Longitudinal follow-up of mixed connective tissue disease and overlapping autoimmune diseases of childhood onset in the Afro-descendant population of the French West Indies	4
Vasculitis in a patient with mevalonate kinase deficiency (MKD): a case report	4
Neutrophil activation in juvenile dermatomyositis: associations with muscle function and disease progression	4
Tumor necrosis factor inhibitors for pediatric patients with SAPHO syndrome associated with acne conglobata	4
Monoarticular juvenile idiopathic arthritis as a distinct clinical entity A proof-of-concept study	4
A narrative review of the literature on illness uncertainty in hypermobile ehlers-danlos syndrome: implications for research and clinical practice	4
Kawasaki disease in neonates: a case report and literature review	4
A tale of two regions: comparing clinical features and outcomes in pediatric enthesitis-related arthritis	4
A quantitative comparison between the essential medicines for rheumatic diseases in children and young people in Africa and the WHO model list	4
Provider assessment of the temporomandibular joint in Juvenile idiopathic arthritis: a retrospective analysis from the CARRA database	3
Adherence to low-dose methotrexate in children with juvenile idiopathic arthritis using a sensitive methotrexate assay	3
Elevated serum IFN-γand IFN-γ/IL-6 ratio in Kikuchi-Fujimoto disease	3
Kawasaki disease complicated by peripheral artery thrombosis: a case report and literature review	3
The utility of miR-16, miR-146a and miR-155 in serum and urine for juvenile idiopathic arthritis diagnostics and monitoring	3
Defining a therapeutic range for adalimumab serum concentrations in the management of pediatric noninfectious uveitis, a step towards personalized treatment	3
Resource utilization and costs of transitioning from pediatric to adult care for patients with chronic autoinflammatory and autoimmune disorders	3
Extreme Periodic Fever, Aphthous Stomatitis, Pharyngitis, Adenitis (PFAPA): a discrete group of patients	3
Giant bilateral axillary artery aneurysms with left complete obstructive thrombus in intravenous immunoglobulin-sensitive Kawasaki disease: a case report	3
Cyclophosphamide treatment with a comparison in both pediatric rheumatology and pediatric nephrology practices	3
Case report: JAK1/2 inhibition with baricitinib in the treatment of STING-associated vasculopathy with onset in infancy	3
Latent classes of early response trajectories to biologics initiation in juvenile idiopathic arthritis: an analysis of four trials	3
Efficacy of mycophenolate mofetil for the maintenance therapy of anti-AQP4 antibody-positive NMOSD complying with probable sjögren’s disease in a 2-year-old girl: a case report	3
Significance of differential diagnosis for the elucidation of rare and complicated diseases	3
Treat-to-target strategies for the management of familial Mediterranean Fever in children	3
Identifying circRNA-associated-ceRNA networks in juvenile spondyloarthropathies patients	3
Long-term growth and final adult height outcome in childhood-onset systemic lupus erythematosus	3
Resilience and its associations in children with Systemic Lupus Erythematosus and Juvenile Idiopathic Arthritis	3
Approaches and outcomes of adalimumab discontinuation in patients with well-controlled inflammatory arthritis: a systematic search and review	3
Long-term safety of canakinumab in patients with systemic juvenile idiopathic arthritis: 5-year results from the Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry	3
Clinical characteristics and risk factors of coronary artery lesions in chinese pediatric Takayasu arteritis patients: a retrospective study	3
Integrative machine learning identifies robust inflammation-related diagnostic biomarkers and stratifies immune-heterogeneous subtypes in Kawasaki disease	3
Antibodies to histone in the pediatric population: a retrospective chart review	3
Retropharyngeal abscess-like as an atypical presentation of Kawasaki disease: a case report and literature review	3
New avenues in childhood vasculitis	3
Pulmonary manifestations of childhood-onset primary Sjogren’s syndrome (SS) masquerading as reactive airways disease in a male patient and review of interstitial lung disease associated with SS	3
Proceedings from the 4th NextGen Therapies for SJIA and MAS virtual symposium held February 13–14, 2022	3
Impact of physiotherapy on orofacial manifestations of juvenile idiopathic arthritis	3
Cardiac repolarization abnormalities in children with familial Mediterranean fever	3
Clinical profile and long-term outcomes of pediatric-onset Takayasu’s arteritis: data from a mexican national referral center	3
Bridging gaps: a qualitative inquiry on improving paediatric rheumatology care among healthcare workers in Kenya	3
Perspectives and experiences of parents of children with juvenile dermatomyositis: a semi-structured interview study	3
Proteomics based markers of clinical pain severity in juvenile idiopathic arthritis	3
Unmet needs and research gaps in Still’s disease across ages: proceedings from a pediatric and adult joint expert panel	3
Correction to: Touraine-Solente-Gole syndrome: pathogenic variant in SLCO2A1 presented with polyarthralgia and digital clubbing	3
Shaping the future of pediatric rheumatology	3
First-line options for systemic juvenile idiopathic arthritis treatment: an observational study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans	3
Is it possible to extend the dose interval of canakinumab treatment in children with familial Mediterranean fever? PeRA group experience	3
Successful experience of tofacitinib treatment in patients with Fibrodysplasia Ossificans Progressiva	3
Causal relationship between serum metabolites and juvenile idiopathic arthritis: a mendelian randomization study	3
A Chinese child with both systemic lupus erythematosus coexisting with neuromyelitis optica spectrum disorder: a case report	3
Unexpectedly high incidence of Kawasaki Disease in a Canadian Atlantic Province- an 11-year retrospective descriptive study	2
TNFAIP3 mutation causing haploinsufficiency of A20 with a hemophagocytic lymphohistiocytosis phenotype: a report of two cases	2
Proceedings of the 27th European Paediatric Rheumatology Congress (PReS 2021)	2
A case series on recurrent and persisting IgA vasculitis (Henoch Schonlein purpura) in children	2
Similarities and differences between MIS-C and KD: a systematic review and meta-analysis	2
Correction: Intraarticular steroids as DMARD-sparing agents for juvenile idiopathic arthritis flares: Analysis of the Childhood Arthritis and Rheumatology Research Alliance Registry	2
ANCA-associated vasculitis with cardiac valve vegetations in two teenage males: two case reports and a literature review	2
Influenza vaccination in patients with juvenile idiopathic arthritis under different treatments: safety and immune response	2
Treatment of thrombosis in KD Patients using tissue plasminogen activator: a single center study	2
IgG4 related pericardium and lung disease in pediatric patient complicated with fatal massive hemoptysis: a case report and review of literature	2
Survey of adolescents’ needs and parents’ views on sexual health in juvenile idiopathic arthritis	2
Correction: the characteristics of video capsule endoscopy in pediatric Henoch–Schönlein purpura with gastrointestinal symptoms	2
Mevalonate kinase deficiency: genetic and clinical characteristics of a Chinese pediatric cohort	2
Unravelling the clinical heterogeneity of undefined recurrent fever over time in the European registries on Autoinflammation	2
Progressive, refractory macrophage activation syndrome as the initial presentation of anti-MDA5 antibody positive juvenile dermatomyositis: a case report and literature review	2